This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Keryx Biopharmaceuticals' Zerenex(TM) (Ferric Citrate Coordination Complex) Data Selected For Oral And Poster Presentations At The American Society Of Nephrology's Kidney Week 2013

Stocks in this article: KERX

NEW YORK, Oct. 17, 2013 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that abstracts highlighting Zerenex™ (ferric citrate coordination complex), the Company's drug candidate for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with chronic kidney disease (CKD) on dialysis, have been selected for oral and poster presentations during the American Society of Nephrology (ASN) Kidney Week 2013 annual meeting. This annual meeting of the ASN will be held in Atlanta, Georgia, from November 5-10, 2013.

Summary of Zerenex™ (ferric citrate coordination complex) Data Presentations:

ORAL PRESENTATION:

Saturday, November 9th:

Abstract#: SA-OR083 - Title: Ferric Citrate, a Phosphate Binder, Increases Iron Stores but Is Not Associated with Evidence of the Malnutrition-Inflammation-Cachexia Syndrome - Session Name: Dialysis: Anemia, Inflammation, Malnutrition, and Metabolism - Presentation Time: 5:30pm

CLINICAL POSTER PRESENTATIONS:

Thursday, November 7th:

Abstract #: TH-PO521 - Title: Ferric Citrate as a Phosphate Binder Reduces IV Iron and Erythropoietin Stimulating Agent (ESA) Use - Session Name: Dialysis: Anemia, Inflammation, Malnutrition, & Metabolism - I - Presentation Time: 10:00am

Saturday, November 9th:

Abstract #: SA-PO382 - Title: Achieved Iron Stores and Clinical Outcomes in a Trial of Ferric Citrate as a Phosphate Binder - Session Name: Dialysis: Anemia, Inflammation, Malnutrition, & Metabolism - II - Presentation Time: 10:00am

Abstract #: SA-PO540 - Title: Ferric Citrate as a Phosphate Binder Has a Safety Profile Similar to Sevelamer Carbonate and Calcium Acetate - Session Name: Mineral Disease: CKD-MBD - II - Presentation Time: 10:00am

Abstract #: SA-PO542 - Title: Ferric Citrate Binds Phosphorus, Delivers Iron, and Reduces IV Iron and Erythropoietic Stimulating Agent Use in End-Stage Renal Disease - Session Name: Mineral Disease: CKD-MBD - II - Presentation Time: 10:00am

Abstract #: SA-PO543 - Title: Impact of Ferric Citrate, an Oral Phosphate Binder, on Mineral and Bone Metabolism Markers in Dialysis - Session Name: Mineral Disease: CKD-MBD - II - Presentation Time: 10:00am

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs